Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000250
Chunk: 66

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 66
---
 2024. These costs are included in
“selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations.

The amounts
of revenue and loss of GEDi Cube, included in the Company’s consolidated statements of operations from the Closing Date through
March 31, 2024 are as follows:

| Schedule of consolidated 
 statements of operations |     |   |          |   |
|:-------------------------|:----|:--|:---------|:--|
| Revenues                 |     | $ | —        |   |
| Net loss                 |     | $ | (398,597 | ) |

Consolidated unaudited pro forma information:

The following consolidated pro forma information assumes
that the acquisition of Renovaro Cube took place on July 1, 2023 for the statement of operations for the nine-month period ended March
31, 2024. These amounts have been estimated after applying the Company’s accounting policies:

| Schedule of consolidated 
 proforma information     |     |   |             |   |
|:-------------------------|:----|:--|:------------|:--|
| Revenues                 |     | $ | —           |   |
| Net loss                 |     | $ | (33,622,997 | ) |

NOTE 13 — SUBSEQUENT EVENTS

On April 5, 2024, the Company issued 33,760 shares of common
stock for consulting services valued at $94,190.

On April 9, 2024, the Company
issued a Promissory Note to Paseco ApS in the principal amount of $150,000. The Note bears an interest rate of 10% per annum and shall
mature on June 1, 2024 (the “Maturity Date”). The Company is required to pay interest on the Maturity Date.

From April 15, 2024, to May 7,
2024, the Company issued Promissory Notes to Paseco ApS in the aggregate principal amount of $855,149. The Company received $855,149 in
proceeds. The Notes bear an interest rate of 10% per annum and shall mature on July 1, 2024 (the “Maturity Date”). The Company
is required to pay interest on the Maturity Date.

<div align='center'>35</div>

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking